DOJ Vows to Scrutinize Pharmaceutical Companies under the FCPA

The FCPA broadly prohibits companies from giving anything of value to a foreign official in order to obtain a business advantage, which can include merely acquiring market intelligence. As pharmaceutical companies do increasing business abroad, they face a substantially greater risk of becoming targets of FCPA investigations and prosecutions.